Recurrent Peripheral Primitive Neuroectodermal Tumor: Clinical Trials

3 completed. 3 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	3	Completed 3

Follow Recurrent Peripheral Primitive Neuroectodermal Tumor: new trials by email Literature Review of Recurrent Peripheral Primitive Neuroectodermal Tumor trials Research Report on Recurrent Peripheral Primitive Neuroectodermal Tumor

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) Laboratory Biomarker Analysis, Palbociclib, Pharmacological Study - Advanced Malignant Solid Neoplasm, Recurrent Childhood Ependymoma	Phase 2	Completed	National Cancer Institute (NCI)	23	2018-08-13	2026-04-03
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) Biospecimen Collection, Computed Tomography, FDG-Positron Emission Tomography - Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma	Phase 2	Completed	National Cancer Institute (NCI)	18	2017-11-28	2026-04-21
Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) Tazemetostat - Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma	Phase 2	Completed	National Cancer Institute (NCI)	20	2017-11-13	2026-04-13

Narrower conditions

Ependymoma (3)  ·  Glioma (3)  ·  Hepatoblastoma (3)  ·  Histiocytosis, Langerhans-Cell (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Medulloblastoma (3)  ·  Neuroblastoma (3)  ·  Neuroectodermal Tumors, Primitive, Peripheral (3)  ·  Osteosarcoma (3)  ·  Rhabdoid Tumor (3)  ·  Rhabdomyosarcoma (3)  ·  Sarcoma (3)  ·  Sarcoma, Ewing (3)  ·  Wilms Tumor (3)  ·  Central Nervous System Neoplasms (2)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genetic Diseases, Inborn (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Histiocytosis (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Kidney Diseases (3)  ·  Kidney Neoplasms (3)  ·  Lung Diseases (3)  ·  Lung Diseases, Interstitial (3)  ·  Lymphatic Diseases (3)  ·  Lymphoma (3)  ·  Lymphoproliferative Disorders (3)

Interventions

LY3023414 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Phantoms, Imaging (1)  ·  Specimen Handling (1)  ·  X-Rays (1)  ·  palbociclib (1)  ·  tazemetostat (1)

Sponsors

National Cancer Institute (NCI) (3)

Countries

Puerto Rico (3)  ·  United States (3)

Top investigators

Rajen Mody (1)  ·  Susan N Chi (1)  ·  Theodore W Laetsch (1)

Results publications

PMID 31401903, PMID 39298716

NIH funding

U10CA180886 (3)